Industry Update: Eli Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Industry Update: Providence Therapeutics Commences mRNA PCV Trial in Australia for Brain Cancers
Industry Update: CREATE Medicines Demonstrates B-Cell Depletion & Repeatable Dosing with In Vivo CAR-T
Industry Update: NeuCyte & Grann Pharma Enter Partnership for mRNA-Based Therapies for Rare Neurological Diseases
Industry Update: Adjuva Bio Awarded CELLSCRIPT™ 2026 mRNA Research Grant to Enhance Next-Gen In Vivo Cell Therapies

Overcoming the Barriers of Delivery Chemistry to Achieve Organ Specific Targeting & Offer a Competitive Edge in the mRNA Market

Overcoming the Barriers of Delivery Chemistry to Achieve Organ Specific Targeting & Offer a Competitive Edge in the mRNA Market

By lilymorris | 16 February 2026